Skip to main content
Fig. 2 | Neurological Research and Practice

Fig. 2

From: Neurological management and work-up of neurotoxicity associated with CAR T cell therapy

Fig. 2

MoCA test results during 10 days monitoring period. All 15 patients were treated with CAR T cell therapy. Except for patient 4 and patient 15 all patients were subjected to a daily MoCA test until the 10th day after therapy. MoCA: Montreal Cognitive Assessment. Pat: patient. *Patient 4 was intubated due to severe CRS on day 8, no further testing; # Patient 15 was transferred to palliative care unit on day 7, no further testing

Back to article page